These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 39155390)

  • 1. HDAC6 inhibition disrupts HDAC6-P300 interaction reshaping the cancer chromatin landscape.
    Zamperla MG; Illi B; Barbi V; Cencioni C; Santoni D; Gagliardi S; Garofalo M; Zingale GA; Pandino I; Sbardella D; Cipolla L; Sabbioneda S; Farsetti A; Ripamonti C; Fossati G; Steinkühler C; Gaetano C; Atlante S
    Clin Epigenetics; 2024 Aug; 16(1):109. PubMed ID: 39155390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histone acetylation of glucose-induced thioredoxin-interacting protein gene expression in pancreatic islets.
    Bompada P; Atac D; Luan C; Andersson R; Omella JD; Laakso EO; Wright J; Groop L; De Marinis Y
    Int J Biochem Cell Biol; 2016 Dec; 81(Pt A):82-91. PubMed ID: 27989964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective inhibition of HDAC6 regulates expression of the oncogenic driver EWSR1-FLI1 through the EWSR1 promoter in Ewing sarcoma.
    García-Domínguez DJ; Hajji N; Sánchez-Molina S; Figuerola-Bou E; de Pablos RM; Espinosa-Oliva AM; Andrés-León E; Terrón-Camero LC; Flores-Campos R; Pascual-Pasto G; Robles MJ; Machado I; Llombart-Bosch A; Magagnoli G; Scotlandi K; Carcaboso ÁM; Mora J; de Álava E; Hontecillas-Prieto L
    Oncogene; 2021 Sep; 40(39):5843-5853. PubMed ID: 34345016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assays for Validating Histone Acetyltransferase Inhibitors.
    Waddell AR; Liao D
    J Vis Exp; 2020 Aug; (162):. PubMed ID: 32831305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Restoration of mutant hERG stability by inhibition of HDAC6.
    Li P; Kurata Y; Endang M; Ninomiya H; Higaki K; Taufiq F; Morikawa K; Shirayoshi Y; Horie M; Hisatome I
    J Mol Cell Cardiol; 2018 Feb; 115():158-169. PubMed ID: 29355491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HDAC6-mediated deacetylation of FLOT2 maintains stability and tumorigenic function of FLOT2 in nasopharyngeal carcinoma.
    Luo C; Wen B; Liu J; Yang W
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2024 May; 49(5):687-697. PubMed ID: 39174882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic therapy of cancer with histone deacetylase inhibitors.
    Lakshmaiah KC; Jacob LA; Aparna S; Lokanatha D; Saldanha SC
    J Cancer Res Ther; 2014; 10(3):469-78. PubMed ID: 25313724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acetylation of histone deacetylase 6 by p300 attenuates its deacetylase activity.
    Han Y; Jeong HM; Jin YH; Kim YJ; Jeong HG; Yeo CY; Lee KY
    Biochem Biophys Res Commun; 2009 May; 383(1):88-92. PubMed ID: 19344692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trichostatin A enhances acetylation as well as protein stability of ERalpha through induction of p300 protein.
    Kim SH; Kang HJ; Na H; Lee MO
    Breast Cancer Res; 2010; 12(2):R22. PubMed ID: 20388208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of HDAC6-mediated progesterone receptor expression on the response of breast cancer cells to hormonal therapy.
    Ramadan WS; Alseksek RK; Mouffak S; Talaat IM; Saber-Ayad MM; Menon V; Ilce BY; El-Awady R
    Eur J Pharmacol; 2024 Nov; 983():177001. PubMed ID: 39284403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromatin remodeling pathways in smooth muscle cell differentiation, and evidence for an integral role for p300.
    Spin JM; Quertermous T; Tsao PS
    PLoS One; 2010 Dec; 5(12):e14301. PubMed ID: 21179216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of histone deacetylase 6 destabilizes ERK phosphorylation and suppresses cancer proliferation via modulation of the tubulin acetylation-GRP78 interaction.
    Wattanathamsan O; Chantaravisoot N; Wongkongkathep P; Kungsukool S; Chetprayoon P; Chanvorachote P; Vinayanuwattikun C; Pongrakhananon V
    J Biomed Sci; 2023 Jan; 30(1):4. PubMed ID: 36639650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Therapeutic Strategy of HDAC6 Inhibitors in Lymphoproliferative Disease.
    Cosenza M; Pozzi S
    Int J Mol Sci; 2018 Aug; 19(8):. PubMed ID: 30096875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HDAC Inhibitors.
    Olzscha H; Bekheet ME; Sheikh S; La Thangue NB
    Methods Mol Biol; 2016; 1436():281-303. PubMed ID: 27246222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic Mechanisms Underlying Organic Solute Transporter
    Zhou Y; Ye C; Lou Y; Liu J; Ye S; Chen L; Lei J; Guo S; Zeng S; Yu L
    Mol Pharmacol; 2020 Apr; 97(4):259-266. PubMed ID: 32005758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tektin4 loss promotes triple-negative breast cancer metastasis through HDAC6-mediated tubulin deacetylation and increases sensitivity to HDAC6 inhibitor.
    Ge LP; Jin X; Yang YS; Liu XY; Shao ZM; Di GH; Jiang YZ
    Oncogene; 2021 Mar; 40(12):2323-2334. PubMed ID: 33654196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of MET signaling by HDAC6 offers a rationale for a novel ricolinostat and crizotinib combinatorial therapeutic strategy in diffuse large B-cell lymphoma.
    Liu Z; Cai Y; Yang Y; Li A; Bi R; Wang L; Shen X; Wang W; Jia Y; Yu B; Cao B; Cui W; Wei P; Zhou X
    J Pathol; 2018 Oct; 246(2):141-153. PubMed ID: 29876933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic control of microsomal prostaglandin E synthase-1 by HDAC-mediated recruitment of p300.
    Fork C; Vasconez AE; Janetzko P; Angioni C; Schreiber Y; Ferreirós N; Geisslinger G; Leisegang MS; Steinhilber D; Brandes RP
    J Lipid Res; 2017 Feb; 58(2):386-392. PubMed ID: 27913583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tubastatin A suppresses renal fibrosis via regulation of epigenetic histone modification and Smad3-dependent fibrotic genes.
    Choi SY; Ryu Y; Kee HJ; Cho SN; Kim GR; Cho JY; Kim HS; Kim IK; Jeong MH
    Vascul Pharmacol; 2015 Sep; 72():130-40. PubMed ID: 25921924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sepsis and glucocorticoids upregulate p300 and downregulate HDAC6 expression and activity in skeletal muscle.
    Alamdari N; Smith IJ; Aversa Z; Hasselgren PO
    Am J Physiol Regul Integr Comp Physiol; 2010 Aug; 299(2):R509-20. PubMed ID: 20538901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.